‘Cruel’ and ‘heartless’ Pharmac decisions rile breast cancer pressure group

+News

‘Cruel’ and ‘heartless’ Pharmac decisions rile breast cancer pressure group

NZD

New Zealand Doctor Rata Aotearoa

petition
Two petitions presented to MPs demanding Pharmac extend funding for Ibrance and Kadcyla cancer drugs have now gathered more than 42,000 signatures
Pharmac’s limitations on new drugs for breast cancer patients have provoked a lobby group backlash. Breast Cancer Aotearoa Coalition (BCAC) chair L, Libby Burgess, Breast Cancer Aotearoa Coalition chair Libby Burgess called Pharmac limiting access to Ibrance “cruel” and “heartless”